Top Markets
Coin of the day
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Pozycja w akcjach #37014
Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating... Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating therapies for the acute phase of thrombotic conditions. The company's lead compound, glenzocimab, is a humanized monoclonal antibody fragment specifically designed to target a particular platelet glycoprotein. Currently, Acticor Biotech is advancing two clinical programs, both in Phase II/III, for the registration of treatments for ischemic stroke. Additionally, it is conducting two other Phase II trials concerning significant cardiovascular emergencies, with anticipated clinical data expected from both its ischemic stroke research and studies related to COVID-19 respiratory distress syndrome. Established in 2013, the company operates from its headquarters in Paris, France.
Cena akcji
$0.25974701
Ostatnia synchronizacja: 2025-01-06
Kapitalizacja rynkowa
$2.04M
Zmiana (1 dzień)
0.74%
Zmiana (1 rok)
0.00%
Kraj
FR
Handel Acticor Biotech SAS (ALACT)

Kategoria

Historia ceny akcji dla Acticor Biotech SAS (ALACT)
Najwyższa cena zamknięcia: $0.26 dnia 2025-01-01

Najniższa cena zamknięcia: $7.56 dnia 2021-11-01
Historia cen akcji firmy Acticor Biotech SAS od 2021 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2025 -4.45%
2024 -91.43%
2023 -58.60%
2022 31.92%
2021 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$515.26 31.04%
US
$987.98 30.54%
NL
$122.35 -10.30%
AU
$142.87 498.26%
US
$697.62 1.32%
CH